Literature DB >> 18451758

Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).

.   

Abstract

At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine vaccination of children aged 2-10 years against meningococcal disease unless the child is at increased risk for the disease. This report summarizes the deliberations of ACIP and the rationale for its decision and restates existing recommendations for meningococcal vaccination among children aged 2-10 years at increased risk for meningococcal disease. ACIP continues to recommend routine vaccination against meningococcal disease for all persons aged 11-18 years and those persons aged 2-55 years who are at increased risk for meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451758

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

Review 1.  Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.

Authors:  Emma D Deeks
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

Review 2.  An update on childhood and adolescent vaccines.

Authors:  Robert M Jacobson
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

5.  Surveillance for invasive meningococcal disease in children, US-Mexico border, 2005-2008.

Authors:  Enrique Chacon-Cruz; David E Sugerman; Michele M Ginsberg; Jackie Hopkins; Jose Antonio Hurtado-Montalvo; Jose Luis Lopez-Viera; Cesar Arturo Lara-Muñoz; Rosa M Rivas-Landeros; Maria Luisa Volker; John A Leake
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

6.  The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic Sensitization.

Authors:  Hongxia Zhao; Cheol-In Kang; Mark S Rouse; Robin Patel; Hirohito Kita; Young J Juhn
Journal:  Int J Microbiol       Date:  2011-11-17

7.  Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age.

Authors:  Scott A Halperin; Yaela Baine; Joseph B Domachowske; Naresh Aggarwal; Michael Simon; Joanne M Langley; Shelly A McNeil; Leonard R Friedland; Veronique Bianco; Carmen I Baccarini; Jacqueline M Miller
Journal:  J Pediatric Infect Dis Soc       Date:  2013-10-17       Impact factor: 3.164

Review 8.  Prevention and treatment of infectious complications after solid organ transplantation in children.

Authors:  Upton Allen; Michael Green
Journal:  Pediatr Clin North Am       Date:  2010-04       Impact factor: 3.278

9.  COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology.

Authors:  Frances Tse; Paul Moayyedi; Kevin A Waschke; Mark MacMillan; Nauzer Forbes; Matthew W Carroll; Nicholas Carman; Grigorios I Leontiadis
Journal:  J Can Assoc Gastroenterol       Date:  2021-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.